These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15619762)

  • 1. Research profile. Anti-psychotic drugs. Can they cause type 2? Paul E. Keck, Jr., MD.
    Kordella T
    Diabetes Forecast; 2004 Dec; 57(12):65-7. PubMed ID: 15619762
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes in treatment with antipsychotic drugs: who is at risk]].
    Deuschle M
    MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.
    Gianfrancesco F; Wang RH; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):9-17. PubMed ID: 16517448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics and diabetes: is there an association?
    Mamdani M
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):403-5. PubMed ID: 15924333
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study focuses in on potential cause of antipsychotic-induced diabetes.
    O'Neill MF
    Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset type-2 diabetes associated with atypical antipsychotic medications.
    Lambert MT; Copeland LA; Sampson N; Duffy SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):919-23. PubMed ID: 16581171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic prescribing and diabetes.
    Agius M; Murphy CL; Win A; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):89-90. PubMed ID: 17603422
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic medication and diabetes mellitus.
    Citrome LL
    J Clin Psychiatry; 2005 Mar; 66(3):395; author reply 395. PubMed ID: 15766309
    [No Abstract]   [Full Text] [Related]  

  • 10. On confounded fishy results regarding arsenic and diabetes.
    Longnecker MP
    Epidemiology; 2009 Nov; 20(6):821-3; discussion e1-2. PubMed ID: 19730267
    [No Abstract]   [Full Text] [Related]  

  • 11. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS; Prous J
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia.
    Cohen D
    J Clin Psychopharmacol; 2008 Aug; 28(4):461-2; author reply 462-4. PubMed ID: 18626279
    [No Abstract]   [Full Text] [Related]  

  • 13. New-onset type II diabetes mellitus, hyperosmolar non-ketotic coma, rhabdomyolysis and acute renal failure in a patient treated with sulpiride.
    Toprak O; Cirit M; Ersoy R; Uzüm A; Ozümer O; Cobanoğlu A; Tanrisev M; Güleç D; Cetinkalp S
    Nephrol Dial Transplant; 2005 Mar; 20(3):662-3. PubMed ID: 15735255
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical antipsychotics, elderly patients, and mortality risk.
    Citrome L
    South Med J; 2007 Oct; 100(10):964-5. PubMed ID: 17943033
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of risperidone on ghrelin and glucose in schizophrenia.
    Cohen D
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):576. PubMed ID: 17875041
    [No Abstract]   [Full Text] [Related]  

  • 17. Research profile. Warding off type 2. Can taking glitazones cut the risk? Philip A. Kern, MD.
    Kordella T
    Diabetes Forecast; 2003 Jun; 56(6):113-5. PubMed ID: 15858895
    [No Abstract]   [Full Text] [Related]  

  • 18. More evidence of an association between antipsychotic drugs and the risk of diabetes in children and adolescents: a population-based study.
    Bobo WV
    Evid Based Ment Health; 2015 May; 18(2):e1. PubMed ID: 25743447
    [No Abstract]   [Full Text] [Related]  

  • 19. Research profile. High blood pressure in type 2. A new culprit? Kieren J. Mather, MD.
    Kordella T
    Diabetes Forecast; 2003 Aug; 56(8):81-3. PubMed ID: 15317078
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
    Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
    CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.